The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis

Journal of Rheumatology

Volumn 26, Issue 6, 1999, Pages 1230-1238

  Kida, Daihei ^b   Yoneda, Masahiko ^b   Miyaura, Shyuichi ^b   Ishimaru, Takeshi ^b   Yoshida, Yuko ^b   Ito, Takayasu ^b   Ishiguro, Naoki ^b   Iwata, Hisashi ^b   Kimata, Koji ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Bikunin; Hyaluronan; Inter trypsin inhibitor; Serum

Indexed keywords

BINDING PROTEIN; HYALURONIC ACID; INTER ALPHA TRYPSIN INHIBITOR; SERUM DERIVED HYALURONAN ASSOCIATED PROTEIN; ULINASTATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-GLOBULINS; ARTHRITIS, RHEUMATOID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYALURONIC ACID; KNEE JOINT; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OSTEOARTHRITIS; REGRESSION ANALYSIS; SERINE PROTEINASE INHIBITORS; SYNOVIAL FLUID;

EID: 0033032281     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Fraser JR, Laurent TC. Hyaluronan. In: Comper WD, editor. Extracellular matrix. Vol.2. Amsterdam: Harwood Academic Publishers; 1996:141-99.
2. Toole BP. Morphogenetic role of glycosaminoglycans in brain and other tissues. In: Balondes SH, editor. Neuronal recognition. New York: Plenum Publishing: 1976:275-329.
3. Toole BP. Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol 1990;2:839-44.
4. Toole BP. Proteoglycans and hyaluronan in morphogenesis and differentiation. In: Elizabeth DH, editor. Cell biology of extracellular matrix. 2nd ed. New York: Plenum Press; 1991: 305-41.
5. Chen L, Wert SE, Hendrix EM, Russel PT, Cannon M, Larsen WJ. Hyaluronic acid synthesis and gap junction endocytosis are necessary for normal expansion of the cumulus mass. Mol Reprod Dev 1990;26:236-47.
6. Chen L, Russel PT, Larsen WJ. Functional significance of cumulus expansion in the mouse: roles for the preovulatory synthesis of hyaluronic acid within the cumulus mass. Mol Reprod Dev 1993;34:87-93.
7. Knudson W, Biswas C, Li XQ, Nemec RE, Toole BP. The role and regulation of tumour-associated hyaluronan. Ciba Found Symp 1989;143:150-9.
8. West DC, Kumar S. Hyaluronan and angiogenesis. Ciba Found Symp 1989;143:187-201.
9. Weigel PH, Frost SJ, LeBoeuf RD, McGary CT. The specific interaction between fibrin(ogen) and hyaluronan: possible consequences in haemostasis, inflammation and wound healing. Ciba Found Symp 1989;143:248-61.
10. Fosang JA, Hardingham TE. Matrix proteoglycans. In: Comper WD, editor. Extracellular matrix. Vol. 2. Amsterdam: Harwood Academic Publishers; 1996:200-29.
11. Underhill C. CD44: the hyaluronan receptor. J Cell Sci 1992;103:293-8.
12. Lee TH, Wisniewski HG, Vilcek J. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J Cell Biol 1992;116:545-57.
13. Doege K, Hassell JR, Caterson B, Yamada Y. Link protein cDNA sequence reveals a tandemly repeated protein structure. Proc Natl Acad Sci USA 1986;83:3761-5.
14. Doege KJ, Sasaki M, Kimura T, Yamada Y. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. J Biol Chem 1991;266:894-902.
15. Shinomura T, Nishida Y, Ito K, Kimata K. cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J Biol Chem 1993;268:14461-9.
16. Yoneda M, Suzuki S, Kimata K. Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85 kDa protein. J Biol Chem 1990;265:5247-57.
17. Huang L, Yoneda M, Kimata K. A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter-α-trypsin inhibitor. J Biol Chem 1993;268:26725-30.
18. Zhao M, Yoneda M, Ohashi Y, et al. Evidence for the covalent binding of SHAP, heavy chains of inter-α-trypsin inhibitor, to hyaluronan. J Biol Chem 1995;270:26657-63.
19. Gebhard W, Hochstrasser K. Inter-α-trypsin inhibitor and its close relatives. In: Barrett AJ, Salvesen G, editors. Proteinase inhibitors. Amsterdam: Elsevier Science Publishers BV; 1986:375-88.
20. Salier JP, Diarra-Mehrpour M, Sesboüé R, et al. Isolation and characterization of cDNAs encoding the heavy chain of human inter-α-trypsin inhibitor (IαTI): unambiguous evidence for multipolypeptide chain structure of IαTI. Proc Natl Acad Sci USA 1987;84:8272-6.
21. Gebhard W, Leysath G, Schreitmüller T. Inter-α-trypsin inhibitor is a complex of three different protein species. Biol Chem Hoppe Seyler 1988;369 Suppl:19-22.
22. Gebhard W, Schreitmüller T, Hochstrasser K, Wachter E. Two out of the three kinds of subunits of inter-α-trypsin inhibitor are structurally related. Eur J Biochem 1989;181:571-6.
23. Salier JP. Inter-α-trypsin inhibitor: emergence of a family within the Kunitz-type protease inhibitor superfamily. Trends Biochem Sci 1990;15:435-9.
24. Diarra-Mehrpour M, Bourguignon J, Bost F, et al. Human inter-α-trypsin inhibitor: full-length cDNA sequence of the heavy chain H1. Biochem Biophys Acta 1992;1132:114-8.
25. Ødum L. Biosynthesis of inter-α-trypsin inhibitor and α1-microglobulin in a human hepatoma cell line. Int J Biochem 1992;24:215-22.
26. Morelle W, Capon C, Balduyck M, et al. Chondroitin sulfate covalently cross-links the three polypeptide chains of inter-α-trypsin inhibitor. Eur J Biochem 1994;221:881-8.
27. Enghild JJ, Thøgersen IB, Pizzo SV, Salvesen G. Analysis of inter-α-trypsin inhibitor and a novel trypsin inhibitor, pre-α-trypsin inhibitor, from human plasma. Polypeptide chain stoichiometry and assembly by glycan. J Biol Chem 1989;264:15975-81.
28. Enghild JJ, Salvesen G, Hefta SA, Thøgersen IB, Rutherfurd S, Pizzo SV. Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-α-inhibitor. J Biol Chem 1991;266:747-51.
29. Bourguignon J, Diarra-Mehrpour M, Thiberville L, Bost F, Sesboüé R, Martin JP. Human pre-α-trypsin inhibitor-precursor heavy chain. cDNA and deduced amino-acid sequence. Eur J Biochem 1993;212:771-6.
30. Reisinger P, Hochstrasser K, Albrecht GJ, Lempart K, Salier JP. Human inter-α-trypsin inhibitor: localization of the Kunitz-type domains in the N-terminal part of the molecule and their release by a trypsin-like proteinase. Biol Chem Hoppe Seyler 1985; 366:479-83.
31. Sandson J, Hamerman D, Schwick G. Altered properties of pathological hyaluronate due to a bound inter-alpha trypsin inhibitor. Trans Assoc Am Physicians 1965;78:304-13.
32. Becker A, Sandson J. The source of the inter-alpha trypsin inhibitor in pathologic hyaluronate protein. Arthritis Rheum 1971;14:764-6.
33. Smith MM, Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987;7:113-22.
34. Hamerman D, Wood DD. Interleukin 1 enhances synovial cell hyaluronate synthesis. Proc Soc Exp Biol Med 1984;177:205-10.
35. Butler DM, Vitti GF, Leizer T, Hamilton JA. Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor α, tumor necrosis factor ß (lymphotoxin), interleukin-1α, and interleukin-1ß. Arthritis Rheum 1988;31:1281-9.
36. Eriksson S, Fraser JR, Laurent TC, Pertoft H, Smedsrod B. Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 1983;144:223-8.
37. Fraser JR, Engström-Laurent A, Nyberg A, Laurent TC. Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis. J Lab Clin Med 1986;107:79-85.
38. Engström-Laurent A, Loof L, Nyberg A, Schroder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985;5:638-42.
39. Engström-Laurent A, Hällgren R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985;44:83-8.
40. Engström-Laurent A, Hällgren R. Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum 1987;30:1333-8.
41. Poole AR, Witter J, Roberts N, et al. Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum 1990;33:790-9.
42. Goldberg RL, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJ. Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991;34:799-807.
43. Paimela L, Heiskanen A, Kurki P, Helve T, Leirisalo-Repo M. Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum 1991;34:815-21.
44. Partsch G, Leeb B, Stancikova M, et al. Low serum hyaluronan in psoriatic arthritis patients in comparison to rheumatoid arthritis patients. Clin Exp Rheurnatol 1996;14:381-6.
45. Emlen W, Niebur J, Flanders G, Rutledge J. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity. J Rheumatol 1996;23:974-8.
46. Kongtawelert P, Ghosh P. A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labeled avidin-biotin technique. Anal Biochem 1990;185:313-8.
47. Tengblad A. Quantitative analysis of hyaluronate in nanogram amounts. Biochem J 1980;185:101-5.
48. Arnett FC, Edworthy SM, Bloch DA, et al. American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
49. Lansbury J, Haut DD. Quantitation of the manifestations of rheumatoid arthritis. Am J Med Sci 1957;232:150-5.
50. Lansbury J. Report of a three year study on the systemic and articular indexes in rheumatoid arthritis. Arthritis Rheum 1959;233:505-22.
51. Steinbuch M. The inter-α-trypsin inhibitor. Methods Enzymol 1976;45:760-72.
52. Chen L, Mao SJ, McLean LR, Powers RW, Larsen WJ. Proteins of the inter-α-trypsin inhibitor family stabilize the cumulus extracellular matrix through their direct binding with hyaluronic acid. J Biol Chem 1994;269:28282-7.
53. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor a but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
54. Shore A, Jaglal S, Keystone EC. Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol 1986;65:293-302.
55. Edwards JC, Mackey AR, Sedgwick AD, Willoughby DA. Mode of formation of synovial villi. Ann Rheum Dis 1983;42:585-90.
56. Resnick D. Arthrography, tenography, and bursography. In: Resnick D, Niwayama G, editors. Diagnosis of bone and joint disorders. Philadelphia: WB Sanders; 1988:302-444.
57. Hutadilok N, Ghosh P, Brooks PM. Binding of haptoglobin, inter-α-trypsin inhibitor, and α1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals. Ann Rheum Dis 1988;47:377-85.
58. Hirashima Y, Kobayashi H, Gotoh J, Terao T. Inter-α-trypsin inhibitor is concentrated in the pericellular environment of mouse granulosa cells through hyaluronan-binding. Eur J Obstet Gynecol Reprod Biol 1997;73:79-84.
59. Chen L, Mao SJ, Larsen WJ. Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix. A role for a member of the inter-α-trypsin inhibitor family. J Biol Chem 1992;267:12380-6.
60. Blom A, Pertoft H, Fries E. Inter-α-trypsin inhibitor is required for the formation of the hyaluronan-containing coat on fibroblasts and mesothelial cells. J Biol Chem 1995;270:9698-701.
61. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
62. Wisniewski HG, Burgess WH, Oppenheim JD, Vilcek J. TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-α-inhibitor. Biochemistry 1994;33:7423-9.
63. Wisniewski HG, Hua JC, Poppers DM, Naime D, Vilcek J, Cronstein BN. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-α-inhibitor and exerts a strong antiinflammatory effect in vivo. J Immunol 1996;156:1609-15.
64. Wisniewski HG, Vilcek J. TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity. Cytokine Growth Factor Rev 1997;8:143-56.
65. Balduyck M, Mizon C, Loutfi H, Richet C, Roussel P, Mizon J. The major human urinary trypsin inhibitor is a proteoglycan. Eur J Biochem 1986;158:417-22.
66. Selloum L, Davril M, Mizon C, Balduyck M, Mizon J. The effect of the glycosaminoglycan chain removal on some properties of the human urinary trypsin inhibitor. Biol Chem Hoppe Seyler 1987;368:47-55.
67. Yuki Y, Nomura K, Kirihara M, et al. Charge isomers of urinary bikunin (trypsin inhibitor). Biochem Biophys Acta 1993;1203:298-303.
68. Delaria KA, Muller DK, Marlor CW, et al. Characterization of placental bikunin, a novel human serine protease inhibitor. J Biol Chem 1997;272:12209-14.
69. McKeehan WL, Sakagami Y, Hoshi H, McKeehan KA. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J Biol Chem 1986;261:5378-83.